Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine‐busulfan‐cyclophosphamide‐based conditioning-Reference-Cited by-同舟云学术

Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine‐busulfan‐cyclophosphamide‐based conditioning

Published:2021-11-08 Issue:2 Volume:26 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatric Transplantation

Author:

Li Guifang¹²^ORCID,Sun Zimin²³,Geng Liangquan²,Wan Xiang²,Zhu Xiaoyu²³,Tang Baolin²,Tong Juan²^ORCID,Yao Wen²,Song Kaidi²,Qiang Ping²,Zhang Lei²,Zhang Xuhan²,Zhang Shiyang¹,Liu Huilan²³

Affiliation:

1. Division of Life Sciences and Medicine Department of Geriatrics The First Affiliated Hospital of USTC University of Science and Technology of China Hefei China

2. Division of Life Sciences and Medicine Department of Hematology The First Affiliated Hospital of USTC University of Science and Technology of China Hefei China

3. Division of Life Sciences and Medicine Blood and Cell Therapy InstituteUniversity of Science and Technology of China Hefei China

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.14181

Reference25 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors

3. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases European Working Group on Myelodysplastic Syndromes in Childhood (EWOG‐MDS);Niemeyer CM;Blood,1997

4. Juvenile myelomonocytic leukemia: who’s the driver at the wheel?

5. JMML genomics and decisions